로딩 중…
지수 로딩 중…
Avalyn Pharma Inc. Common Stock
AVLN· NASDAQ· Health Care
$33.57-3.17%
2026-09-11
Financials
Valuation Metrics
Avalyn Pharma Inc. Common Stock's Market Cap is $1.49B. Ranked #2204 of 3,118 in US market (top 71%), #874 of 1,460 on NASDAQ (top 60%) by Market Cap.
Investment Metrics(as of 2026-09-11)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.49B | US#2,204/3,118 |
| Revenue | $0.00 | US#2,889/3,118 |
| Net Income | $-85M | US—/3,118 |
| Total Assets | $149M | US#3,034/3,118 |
| Net Assets | $-239M | US#3,001/3,118 |
| Value | ||
| FCF Yield | -5.50% | US—/3,118 |
| Profitability | ||
| ROA | -57.23% | US#3,015/3,118 |
| Financial Health | ||
| Total Debt | $2M | US#2,974/3,118 |
| FCF | $-82M | US#2,594/3,118 |
| Cash | $52M | US#2,561/3,118 |
| Current Ratio | 10.19x | US#251/3,118 |
| Performance | ||
| 1M Return | -10.19% | US#1,333/3,118 |
| From 52W High | -16.43% | US#1,041/3,118 |
| 1Y MDD | -22.11% | US#870/3,118 |
| Trading | ||
| Volume | 130,194 shares | US#2,832/3,118 |
| Trading Value | $4M | US#2,679/3,118 |
| Per Share | ||
| EPS | $-1.92 | US—/3,118 |
| BPS | $-5.38 | US—/3,118 |